Ulf Arne Wiinberg

Ulf Arne Wiinberg

Directeur/Membre du Conseil chez UCB

Fortune : 1 M $ au 30/04/2024

66 ans
Health Technology
Producer Manufacturing
Commercial Services

Profil

Ulf Arne Wiinberg is currently the President & Chief Executive Officer at X-Vax Technology, Inc., Chairman & Chief Executive Officer at Ulf Wiinberg Consult & Invest AB, Chairman at Lund Science AB, Chairman at Sigrid Therapeutics AB, Independent Director at Agenus, Inc., Independent Director at UCB SA, Independent Director at Alfa Laval AB, Director at International Federation of Pharmaceutical Manufacturers, Director at European Federation of Pharmaceutical Industries & Assns, Director at Lexington Group, Inc., Director at Wallon Institute for Life Lead Sciences, Director at UCB Pharma AB, Independent Director at MiNK Therapeutics, Inc., and Director at AgenTus Therapeutics SA. He previously served as the President & Chief Executive Officer at H.
Lundbeck A from 2008 to 2014, Chairman at Hansa Biopharma AB from 2016 to 2022, Chairman & Manager-Human Resources at Trialbee AB, Chairman at Avillion LLP, Director-Europe, Middle East & Africa Region at Wyeth Pharmaceuticals LLC, Managing Director at John Wyeth & Brother Ltd., Director at Pharmaceutical Research & Manufacturers of America, Director at The European Medicines Agency, Director at Nestle Health Science SA, President-Europe, Middle East & Africa Region at Wyeth LLC from 2002 to 2008, President at Wyeth Consumer Healthcare, Inc. from 2002 to 2005, and President at Wyeth BioPharma.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2022 20 000 ( 0,00% ) 862 982 $ 30/04/2024
01/03/2024 368 633 ( 1,06% ) 321 079 $ 30/04/2024
17/04/2024 6 203 ( 0,03% ) 51 485 $ 30/04/2024

Postes actifs de Ulf Arne Wiinberg

SociétésPosteDébut
ALFA LAVAL AB Directeur/Membre du Conseil 23/04/2013
UCB Directeur/Membre du Conseil 28/04/2016
AGENUS INC. Directeur/Membre du Conseil 17/05/2016
MINK THERAPEUTICS, INC. Directeur/Membre du Conseil 01/07/2017
UCB Pharma AB Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Lund Science AB Président -
Directeur Général -
Wallon Institute for Life Lead Sciences Directeur/Membre du Conseil -
░░░ ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░ -
░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░ -
Tous les postes actifs de Ulf Arne Wiinberg

Anciens postes connus de Ulf Arne Wiinberg

SociétésPosteFin
░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Ulf Arne Wiinberg

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ulf Arne Wiinberg

Relations

100 +

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées6
AGENUS INC.

Health Technology

H. LUNDBECK A/S

Health Technology

UCB

Health Technology

ALFA LAVAL AB

Producer Manufacturing

HANSA BIOPHARMA AB

Health Technology

MINK THERAPEUTICS, INC.

Health Technology

Entreprise privées20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Distribution Services

The European Medicines Agency

Government

Wallon Institute for Life Lead Sciences

Health Technology

Lund Science AB

Technology Services

Health Technology

Health Technology

UCB Pharma AB

Health Technology

Finance

AgenTus Therapeutics SA

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Ulf Arne Wiinberg